Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.METABOL.2020.154341 | ||||
| Año | 2020 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Background: Biallelic loss of function variants in AGPAT2, encoding 1-acylglycerol-3-phosphate O-acyltransferase 2, cause congenital generalized lipodystrophy type 1, a disease characterized by near total loss of white adipose tissue and metabolic complications. Agpat2 deficient (Agpat2−/−) mice completely lacks both white and interscapular brown adipose tissue (iBAT). The objective of the present study was to characterize the effects of AGPAT2 deficiency in brown adipocyte differentiation. Methods: Preadipocytes obtained from newborn (P0.5) Agpat2−/− and wild type mice iBAT were differentiated into brown adipocytes, compared by RNA microarray, RT-qPCR, High-Content Screening (HCS), western blotting and electron microscopy. Results: 1) Differentiated Agpat2−/− brown adipocytes have fewer lipid-laden cells and lower abundance of Pparγ, Pparα, C/ebpα and Pgc1α, both at the mRNA and protein levels, compared those to wild type cells. Prmd16 levels were equivalent in both, Agpat2−/− and wild type, while Ucp1 was only induced in wild type cells, 2) These differences were not due to lower abundance of preadipocytes, 3) Differentiated Agpat2−/− brown adipocytes are enriched in the mRNA abundance of genes participating in interferon (IFN) type I response, whereas genes involved in mitochondrial homeostasis were decreased, 4) Mitochondria in differentiated Agpat2−/− brown adipocytes had altered morphology and lower mass and contacting sites with lipid droplets concomitant with lower levels of Mitofusin 2 and Perlipin 5. Conclusion: AGPAT2 is necessary for normal brown adipose differentiation. Its absence results in a lower proportion of lipid-laden cells, increased expression of interferon-stimulated genes (ISGs) and alterations in mitochondrial morphology, mass and fewer mitochondria to lipid droplets contacting sites in differentiated brown adipocytes.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | TAPIA-CAMPILLAY, PABLO | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| 2 | Figueroa, Ana-Maria | Mujer |
Pontificia Universidad Católica de Chile - Chile
|
| 3 | EISNER-SAGUES, VERONICA RAQUEL | Mujer |
Pontificia Universidad Católica de Chile - Chile
|
| 4 | Gonzalez-Hodar, Lila | Mujer |
Pontificia Universidad Católica de Chile - Chile
|
| 5 | Robledo, Fermin | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| 6 | Agarwal, Anil K. | Hombre |
UT Southwestern Medical Center - Estados Unidos
Univ Texas Southwestern Med Ctr Dallas - Estados Unidos |
| 7 | Garg, Abhimanyu | - |
UT Southwestern Medical Center - Estados Unidos
Univ Texas Southwestern Med Ctr Dallas - Estados Unidos |
| 8 | CORTES-MORA, VICTOR ANTONIO | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| Fuente |
|---|
| CONICYT (Chile) |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Comisión Nacional de Investigación Científica y Tecnológica |
| FONDECYT (Chile) |
| Comisión Nacional de Investigación CientÃfica y Tecnológica |
| Fondo Nacional de Desarrollo CientÃfico y Tecnológico |
| Conicyt Doctoral scholarship |
| Pontificia Universidad Católica de Chile |
| Southwestern Medical Foundation |
| ANID Doctoral Scholarship |
| CONICYT Doctoral Scholarship (Chile) |
| ANID Doctoral Scholarship (Chile) |
| Agradecimiento |
|---|
| We thank Dr. Jaime Melendez and Facultad de Qu?mica y Farmacia of the Pontificia Universidad Cat?lica de Chile for enabling access to Cytation 5 Cell Imaging Multi-Mode Reader system (Fondequip EQM160042). We also want to acknowledge the important help of Kelly Cautivo for her skillful and constructive criticism and to Susan Smalley for her support in HCS image analysis. V.C. was funded by FONDECYT grant (1181214, Chile). P.J.T. was supported by CONICYT Doctoral Scholarship (21120329, Chile). V.E. was funded by a FONDECYT grant (1991770, Chile). A.M.F. was supported by ANID Doctoral Scholarship (21171743, Chile). L.G.H. was supported by CONICYT Scholarship (21171491, Chile). F.R. was supported by CONICYT Doctoral Scholarship (21171571, Chile). A.G. and A.K.A. were supported by Southwestern Medical Foundation. |
| V.C. was funded by FONDECYT grant (1181214, Chile). P.J.T. was supported by CONICYT Doctoral Scholarship (21120329, Chile). V.E. was funded by a FONDECYT grant (1991770, Chile). A.M.F. was supported by ANID Doctoral Scholarship (21171743, Chile). L.G.H. was supported by CONICYT Scholarship (21171491, Chile). F.R. was supported by CONICYT Doctoral Scholarship (21171571, Chile). A.G. and A.K.A. were supported by Southwestern Medical Foundation. |